“Studies show that THC is effective against glaucoma, however it is important to be attentive to the dosages that each patient needs,” says Dr. Renan Abdalla in Live
In celebration of the National Glaucoma Awareness Day, which takes place today (26), the doctor highlighted the importance of clinical monitoring of patients who use cannabinoid therapy for the treatment of this and other pathologies
By João R. Negromonte
In a live broadcast that aired last Tuesday (24), the general practitioner, Dr. Renan Abdalla, discussed the benefits of cannabis treatment for various diseases, including glaucoma, which affects about 1 million Brazilians according to the World Health Organization (WHO).
>>> Join Sechat's WHATSAPP group and be the first to receive news
“We have studies showing the benefits of THC application in patients with the condition since the 1970s, and even though there is disagreement among some researchers, the results seen in practice are truly surprising,” Abdalla states, referring to a clinical case in which he was directly involved in the treatment of the disease.
The doctor recalls that an elderly patient approached him after trying several other ineffective treatment alternatives for her glaucoma. Upon learning about cannabinoid therapy, she showed a significant decrease in intraocular pressure, the main cause of the condition.
>>> Join Sechat's TELEGRAM group and be the first to receive news
“In her tonometry test - an examination that determines intraocular pressure - the patient had a reduction from 17% to 12% after starting treatment with cannabis,” reveals the general practitioner, emphasizing the importance of the patient being under the care of an ophthalmologist during the process.
Abdalla was also asked about the use of cannabidiol (CBD), a compound that some researchers claim is not the most suitable for glaucoma. He justifies that CBD has anti-inflammatory properties and that there are cannabinoid receptors in the cornea region, so he believes that its use was not harmful. However, he points out that more studies and research are still needed to prove his theory, as each patient may require individualized treatment.
Other topics such as the benefits of cannabis for patients with cancer and fibromyalgia, dosages, the establishment of the Renasce Institute of Research and Education (IRPEE), the lack of a subject on the Endocannabinoid System in universities, and the importance of being under the care of a prescribing professional for those who use this treatment alternative were also highlighted in this live broadcast.
Therefore, for those who did not have time to follow our live broadcast, the opportunity is now. To find out, just hit play on the video below and watch the broadcast that took place on our Instagram channel (@sechat_oficial):